Pages that link to "Q83656504"
Jump to navigation
Jump to search
The following pages link to Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial (Q83656504):
Displaying 50 items.
- Sacral nerve stimulation for faecal incontinence and constipation in adults (Q24187787) (← links)
- Perianal injectable bulking agents as treatment for faecal incontinence in adults (Q24200587) (← links)
- Surgery for faecal incontinence in adults (Q24201396) (← links)
- Faecal incontinence: Current knowledges and perspectives (Q26766667) (← links)
- Management of patients with faecal incontinence (Q26771879) (← links)
- Surgical management for fecal incontinence (Q27013913) (← links)
- Impact of fecal incontinence and its treatment on quality of life in women (Q28085211) (← links)
- Percutaneous tibial nerve stimulation versus sham electrical stimulation for the treatment of faecal incontinence in adults (CONFIDeNT): a double-blind, multicentre, pragmatic, parallel-group, randomised controlled trial (Q28266434) (← links)
- Dextranomer in stabilized sodium hyaluronate (Solesta®): in adults with faecal incontinence (Q28272080) (← links)
- Internal anal sphincter augmentation and substitution (Q33607178) (← links)
- Common anorectal disorders (Q33827923) (← links)
- Endoscopic and imaging appearance after injection of an ano-rectal bulking agent. (Q33891859) (← links)
- Current and emerging treatment options for fecal incontinence (Q34196874) (← links)
- Management of pelvic floor disorders: biofeedback and more (Q34389204) (← links)
- An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women (Q34649730) (← links)
- What's New in the Toolbox for Constipation and Fecal Incontinence? (Q35104452) (← links)
- Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence (Q35211754) (← links)
- Relationship Among Anal Sphincter Injury, Patulous Anal Canal, and Anal Pressures in Patients With Anorectal Disorders (Q36075005) (← links)
- A prospective non-randomized two-centre study of patients with passive faecal incontinence after birth trauma and patients with soiling after anal surgery, treated by elastomer implants versus rectal irrigation (Q36199137) (← links)
- Midterm outcomes of injectable bulking agents for fecal incontinence: a systematic review and meta-analysis (Q36294789) (← links)
- Novel treatment of fecal incontinence with an injectable biocompatible tissue bulking agent (Q36496979) (← links)
- Evidence-Based Update on Treatments of Fecal Incontinence in Women (Q36593492) (← links)
- Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence (Q36659345) (← links)
- Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response (Q36901639) (← links)
- Update on the Management of Fecal Incontinence for the Gastroenterologist (Q36916623) (← links)
- Office-based management of fecal incontinence (Q37078611) (← links)
- Current Trends in Management of Defecatory Dysfunction, Posterior Compartment Prolapse, and Fecal Incontinence (Q37187280) (← links)
- Current management of fecal incontinence (Q37197568) (← links)
- Multicentre observational study of the Gatekeeper for faecal incontinence (Q37337411) (← links)
- Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes (Q37439883) (← links)
- Effects of clonidine in women with fecal incontinence (Q37510329) (← links)
- An update on anorectal disorders for gastroenterologists (Q37552802) (← links)
- Fecal incontinence - Challenges and solutions (Q37572527) (← links)
- Recent Advances in Functional Anorectal Disorders (Q37871422) (← links)
- Anal cancer: are we making progress? (Q38078283) (← links)
- Emerging surgical therapies for faecal incontinence (Q38166181) (← links)
- Fecal incontinence: the role of the urologist (Q38183781) (← links)
- Current status: new technologies for the treatment of patients with fecal incontinence (Q38194462) (← links)
- Pregnancy and postpartum bowel changes: constipation and fecal incontinence (Q38388974) (← links)
- Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders (Q38609589) (← links)
- Overview of High-Risk Medical Device Innovation in Gastroenterology from 2000 to 2014: Enhancing the Pipeline. (Q38784795) (← links)
- Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS). (Q38828657) (← links)
- Endpoints for therapeutic interventions in faecal incontinence: small step or game changer (Q38903812) (← links)
- Treatment of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases workshop (Q39110263) (← links)
- Treatment of sphincter insufficiency (Q39234914) (← links)
- Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence (Q40221158) (← links)
- Fecal Incontinence: Epidemiology, Impact, and Treatment (Q40599030) (← links)
- Severe rectal haemorrhage after treatment for faecal incontinence (Q42058265) (← links)
- Validating endpoints for therapeutic trials in fecal incontinence (Q42408757) (← links)
- Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents (Q43352631) (← links)